The latter function is performed by the islets of Langerhans, cells in the pancreas (named after their discoverer, ...

More than 70 new laws take effect in Florida on July 1, 2025.

TAMPA, Fla. - A series of new laws will go into effect in Florida on July 1, 2025. In fact, more than 70 new laws signed by ...

Maharashtra FDA revoked Zepto's food license in Mumbai's Dharavi after a recent inspection which unveiled dangerous sights of non-compliance from the company's operator.

WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) says it plans to use artificial intelligence (AI) to help speed the approval of new drugs and medical devices.

First FDA-Approved Therapy for Recurrent Low-Grade, Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC): Zusduri (mitomycin) is the first and only FDA-approved intravesical treatment ...

The U.S. Food and Drug Administration has classified the recall as a Class I, the agency's most urgent warning level, signaling the potential for significant public health consequences.

Nearly 1 in 5 positions across the Food and Drug Administration's human food inspection divisions are now vacant, multiple agency officials tell CBS News, in the wake of departures encouraged by ...

Moderna said the FDA approved its new COVID-19 vaccine "for use in all adults 65 and older, as well as individuals aged 12-64 years with at least one or more underlying risk factor." ...

U.S. FDA Approves UroGen’s ZUSDURI™ (mitomycin) for Intravesical Solution as the First and Only Medication for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR ...

TYRA-300 is the only orally administered investigational agent in clinical development for IR NMIBC- -Initial 3-month complete response (CR) data expected to be reported ...